Showing 5,874 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Undetectable viral load & treatment as prevention

Good mental health associated with excellent adherence among people taking ART for prevention

News
23 March 2015
New & experimental HIV treatments

HIV treatment: New inexpensive agents can block virus ability to replicate and develop resistance

Editor's pick
International Business Times
20 March 2015
New & experimental HIV treatments

Cabotegravir and rilpivirine effective for HIV maintenance therapy at 96 weeks

News
19 March 2015
Hepatitis B

WHO issues its first hepatitis B treatment guidelines

Editor's pick
World Health Organization
12 March 2015
Hepatitis C treatment

Sofosbuvir/ledipasvir raises some antiretroviral levels in HIV/HCV coinfected people

News
10 March 2015
The search for a cure

Beware Of Sangamo: 20-Year History Of Failures, Misadventures In HIV, And Flawed Approach In B-Thalassemia

Editor's pick
Seeking Alpha
10 March 2015
The search for a cure

We may need to combine many approaches to achieve a cure, delegates hear

News
9 March 2015
Weight gain & lipodystrophy

Does HIV make you fat? Study connects viral load with fat gains

News
6 March 2015
Treatment interruptions

Markers of Immune Exhaustion Predict Post-Treatment Control in HIV Patients

Editor's pick
The Body
5 March 2015
Bad science & bogus treatments

Pakistan: Factory making fake Hepatitis C drug raided

Editor's pick
The International News
4 March 2015
Weight gain & lipodystrophy

Abdominal Body Fat Gains on ART and Viral Load: It Matters Where You Start

Editor's pick
BETA blog
4 March 2015
New & experimental HIV treatments

HIV attachment inhibitor BMS-663068 safe and effective in phase 2b study

News
4 March 2015
Starting treatment

Early HIV treatment and isoniazid prophylaxis: why TEMPRANO results do not yet support universal ART at CD4 >500 cells/mm3

Editor's pick
HIV i-Base
3 March 2015
Side effects

Tenofovir, boosted atazanavir and boosted lopinavir are associated with cumulative risk of developing chronic kidney disease

News
27 February 2015
Starting treatment

Inflammation Persists Despite Very Early HIV Treatment

Editor's pick
The Body Pro
27 February 2015
HIV treatment

Tenofovir alafenamide equally effective but safer for kidneys and bones than current formulation

News
27 February 2015
New & experimental HIV treatments

48-week analysis of investigational HIV-1 attachment inhibitor paves way for Phase III trial initiation

Editor's pick
Bristol Myers Squibb press release
26 February 2015
New & experimental HIV treatments

HIV maturation inhibitor BMS-955176 looks promising in early study

News
26 February 2015
Starting treatment

Starting HIV treatment at CD4 count above 500 reduces the risk of serious illness and death by 44%, African Temprano trial shows

News
26 February 2015
Treatment simplification strategies

Week-on, weekend-off treatment controls viral load in young people

News
25 February 2015
Vaginal rings & topical PrEP

Disappointing result for tenofovir-gel microbicide shows that young women still lack HIV prevention methods they can use

News
25 February 2015
Pregnancy and vertical transmission

7-country study shows triple-drug combination superior for preventing infant HIV infection

News
25 February 2015
PrEP science

Pre-exposure prophylaxis also stops 86% of HIV infections in Ipergay study

News
24 February 2015
PrEP

Health News Review analysis of Bloomberg's coverage of PrEP

Editor's pick
Health News Review
24 February 2015